Monografie
Development of a Method for the Characterization, Assessment and Control of Human Induced Uncertainty During Usage
- Sprache
-
Englisch
- Identifier
-
1141904748
Thema
Biopharmazie; Pharmakodynamik; Pharmakokinetik; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Biofunctionalization of Silsesquioxane Nanoparticles
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Expression, purification and characterization of human myosin 9a
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
Wirksamkeit und Verträglichkeit eines tenofovirhaltigen Therapieregimes bei HIV1-Patienten nach D-Switch
Generation, enrichment and characterization of bioactive oligosaccharides and peptides from milk
Parallele Synthese, Charakterisierung und zelluläre Pharmakokinetik von fluoreszenten zell-penetrierenden Peptiden = Parallel synthesis, characterization and cellular pharmacokinetics of fluorescent cell-penetrating peptides
Evaluating Ligand Gated Human 5-HT3A Receptor Variants for Anesthetic Studies on Single Channel Level
STAT3 inhibitors for cancer treatment
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") : studies on MDMA metabolism and pharmacokinetics in humans and squirrel monkeys
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia
Therapeutic Drug Monitoring of Antipsychotics - HPLC Analytical Method Development and Pharmaceutical Advices to the Ward Clinicians - For Successful Individualized Therapy
Biofunctionalization of Silsesquioxane Nanoparticles
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Expression, purification and characterization of human myosin 9a
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
Wirksamkeit und Verträglichkeit eines tenofovirhaltigen Therapieregimes bei HIV1-Patienten nach D-Switch
Generation, enrichment and characterization of bioactive oligosaccharides and peptides from milk
Parallele Synthese, Charakterisierung und zelluläre Pharmakokinetik von fluoreszenten zell-penetrierenden Peptiden = Parallel synthesis, characterization and cellular pharmacokinetics of fluorescent cell-penetrating peptides
Evaluating Ligand Gated Human 5-HT3A Receptor Variants for Anesthetic Studies on Single Channel Level
STAT3 inhibitors for cancer treatment
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") : studies on MDMA metabolism and pharmacokinetics in humans and squirrel monkeys
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia
Therapeutic Drug Monitoring of Antipsychotics - HPLC Analytical Method Development and Pharmaceutical Advices to the Ward Clinicians - For Successful Individualized Therapy
Biofunctionalization of Silsesquioxane Nanoparticles
Entry targeted lentiviral vectors for the specific modification of distinct subsets of immune cells
Expression, purification and characterization of human myosin 9a
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
Wirksamkeit und Verträglichkeit eines tenofovirhaltigen Therapieregimes bei HIV1-Patienten nach D-Switch
Generation, enrichment and characterization of bioactive oligosaccharides and peptides from milk
Parallele Synthese, Charakterisierung und zelluläre Pharmakokinetik von fluoreszenten zell-penetrierenden Peptiden = Parallel synthesis, characterization and cellular pharmacokinetics of fluorescent cell-penetrating peptides
Evaluating Ligand Gated Human 5-HT3A Receptor Variants for Anesthetic Studies on Single Channel Level
STAT3 inhibitors for cancer treatment
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") : studies on MDMA metabolism and pharmacokinetics in humans and squirrel monkeys
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia